secwatch / observer
8-K filed November 7, 2022, 6:59 PM ET ticker MAPS CIK 0001779474
leadership confidence high sentiment negative materiality 0.80

WM Technology Q3 net loss $10.5M; CEO Chris Beals resigns

WM TECHNOLOGY, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Chris Beals

Chief Executive Officer and director
MAPS · WM TECHNOLOGY, INC.
Effective
2022-11-07
Filed
November 7, 2022, 6:59 PM ET
On November 3, 2022, Chris Beals, the Company’s Chief Executive Officer and director, tendered his resignation from his role as Chief Executive Officer and from the Board of Directors, effective November 7, 2022.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

WM TECHNOLOGY, INC. reported the third quarter ended September 30, 2022 results: revenue $50.5 million, net income $10.5 million, EPS $0.06.

Period
the third quarter ended September 30, 2022
Revenue
$50.5 million
Net income
$10.5 million
EPS
$0.06
Result
reported results
Exact text from the filing
Revenue was $50.5 million as compared to $50.9 million in the third quarter of 2021.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Chris Beals resigned as Chief Executive Officer and director at WM TECHNOLOGY, INC..

Action
resigned
Role
Chief Executive Officer and director
Exact text from the filing
On November 3, 2022, Chris Beals, the Company’s Chief Executive Officer and director, tendered his resignation from his role as Chief Executive Officer and from the Board of Directors, effective November 7, 2022.
View on SEC.gov

Browse all earnings releases →

WM TECHNOLOGY, INC. filing history →

Source: SEC EDGAR
accession 0001779474-22-000081
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.